澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEUROTECH INTERNATIONAL LTD

0.013

0.000

成交量：363.64萬

成交額：4.74萬

市值：2,100.89萬

市盈率：-2.35

高：0.014

開：0.014

低：0.013

收：0.013

52周最高：0.029

52周最低：0.010

股本：16.16億

流通股本：7.68億

量比：8.75

換手率：0.47%

股息：- -

股息率：- -

每股收益(TTM):-0.006

每股收益(LYR):-0.006

淨資產收益率：-366.75%

總資產收益率：-138.02%

市淨率：34.38

市盈率(LYR):-2.35

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Neurotech International 獲約450萬澳元定向增資承諾，發行價每股0.014澳元

Neurotech International 完成約450萬澳元股份配售，每股定價0.014澳元

Neurotech International宣佈美國FDA已批准NTI164的IND申請

分析-2025年，隨着高價基因療法上市數量減少，美國新藥價格出現下降

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/NTI.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"NTI.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NTI.AU\",,,,,undefined,":{"symbol":"NTI.AU","market":"AU","secType":"STK","nameCN":"NEUROTECH INTERNATIONAL LTD","latestPrice":0.013,"timestamp":1789525417862,"preClose":0.013,"halted":0,"volume":3636385,"delay":0,"changeRate":0,"nameEN":"NEUROTECH INTERNATIONAL LTD","floatShares":768083617,"shares":1616069964,"eps":-0.005531,"marketStatus":"交易中","change":0,"latestTime":"09-16 12:46:55 AEST","open":0.014,"high":0.014,"low":0.013,"amount":47363,"amplitude":0.076923,"askPrice":0.013,"askSize":382649,"bidPrice":0.012,"bidSize":5829399,"shortable":3,"etf":0,"ttmEps":-0.005531,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789538400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.013,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":8.752369,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NTI.AU","preClose":0.013,"auctionPrice":0.014,"auctionVolume":90071,"auctionTime":1789516735610,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789516735610}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NTI.AU\",,,,,undefined,":{"symbol":"NTI.AU","floatShares":768083617,"roa":"-138.02%","roe":"-366.75%","lyrEps":-0.005531,"volumeRatio":8.752369,"shares":1616069964,"dividePrice":0,"high":0.014,"amplitude":0.076923,"preClose":0.013,"low":0.013,"week52Low":0.01,"pbRate":"34.38","psRate":"4.44","week52High":0.029,"institutionHeld":0,"latestPrice":0.013,"committee":0.876804,"eps":-0.005531,"divideRate":0,"volume":3636385,"delay":0,"ttmEps":-0.005531,"open":0.014,"prevYearClose":0.014,"prevWeekClose":0.013,"prevMonthClose":0.014,"prevQuarterClose":0.014,"fiveDayClose":0.013,"twentyDayClose":0.014,"sixtyDayClose":0.013,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTI.AU\",params:#limit:5,,,undefined,":[{"date":"2023-10-27","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1698361200000,"name":null,"time":"","dateTimestamp":1698325200000,"actualEps":null},{"date":"2023-07-26","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1690329600000,"name":null,"time":"","dateTimestamp":1690293600000,"actualEps":null},{"market":"AU","date":"2023-04-27","symbol":"NTI.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1682517600000,"reportTimeType":"","actualEps":null},{"date":"2023-01-30","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1675033200000,"name":null,"time":"","dateTimestamp":1674997200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTI.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTI.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1168763117","title":"Neurotech International 獲約450萬澳元定向增資承諾，發行價每股0.014澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168763117","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168763117?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 09:55","pubTimestamp":1785808538,"startTime":"0","endTime":"0","summary":"Neurotech International Ltd（代码：NTI.AX）宣布，已获得总额约450万澳元的定向增资承诺。此次配售的价格设定为每股0.014澳元。这一消息于8月4日对外公布，标志着公司资本运作迈出关键一步。相关细节已在随后的公司公告中进一步披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTI.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120903726","title":"Neurotech International 完成約450萬澳元股份配售，每股定價0.014澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120903726","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120903726?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 07:29","pubTimestamp":1785799763,"startTime":"0","endTime":"0","summary":"Neurotech International 已获得具有约束力的认购承诺，将通过股份配售募集约450万澳元。此次配售的定价为每股0.014澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","NTI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101553097","title":"Neurotech International宣佈美國FDA已批准NTI164的IND申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1101553097","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101553097?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 09:56","pubTimestamp":1783994192,"startTime":"0","endTime":"0","summary":"Neurotech International Ltd 宣布，其新药NTI164的试验性新药申请已获得美国食品药品监督管理局的批准。\n这一监管进展为该公司推进其候选药物的临床开发计划铺平了道路。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTI.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646794508","title":"分析-2025年，隨着高價基因療法上市數量減少，美國新藥價格出現下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2646794508","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646794508?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 18:01","pubTimestamp":1782381707,"startTime":"0","endTime":"0","summary":"分析-2025年，随着高价基因疗法上市数量减少，美国新药价格出现下降2025年获FDA批准的药品年均标价中位数为216,000美元2025年，FDA批准了51种新药，其中包括5种细胞和基因疗法2025年获批药物中，小分子药物占比超过67%，高于2024年的62%Deena Beasley路透6月25日-一项最新分析显示，2025年美国监管机构批准的处方药上市价格虽较上年有所下降，但受罕见病高价药物影响，中位数仍高达216,000美元。基因疗法通常只需给药一次，其价格可能高达数百万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4S42X0VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4548","JAZZ","LU0109394709.USD","LU0154245673.USD","LU0154245756.USD","LENZ","IE00BN0W2T93.GBP","BK7501","BK4588","LU0114720955.EUR","IE00BN0W2W23.USD","LU0889565916.HKD","CSL.AU","LU0320765992.SGD","ALNY","IE00BN0W2V16.EUR","BK4585","BK7511","BK4539","LU0882574055.USD","BK7508","BK7007","NTI.AU","BK4533","BK4532","BK7067","IONS","LU0823416689.USD","ABEO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NTI.AU\",params:#limit:6,delay:true,,,undefined,":[]}}